{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:22:41Z","timestamp":1777270961356,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences","award":["2022-LC04"],"award-info":[{"award-number":["2022-LC04"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0521900"],"award-info":[{"award-number":["2024ZD0521900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05628-9","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:26:46Z","timestamp":1771486006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Higher fatty liver index is associated with increased risk of incident atrial fibrillation in adults with diabetes: a prospective UK biobank study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xi","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengtong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"8","key":"5628_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74(8):1107\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5628_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, Bardsley JK, Beverly EA, Corbin KD, ElSayed NA, et al. Metabolic Dysfunction-Associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early Intervention. A consensus report of the American diabetes association. Diabetes Care. 2025;48(7):1057\u201382.","journal-title":"Diabetes Care"},{"issue":"2","key":"5628_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/dc20-1778","volume":"44","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Monti T, Perseghin G. High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. Adults with type 2 diabetes. Diabetes Care. 2021;44(2):519\u201325.","journal-title":"Diabetes Care"},{"issue":"2","key":"5628_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","volume":"165","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Wilson LA, Behling C, Kleiner DE, Kowdley KV, Dasarathy S, Amangurbanova M, Terrault NA, Diehl AM, Chalasani N, et al. Fibrosis progression rate in Biopsy-Proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: A multicenter study. Gastroenterology. 2023;165(2):463\u201372. e465.","journal-title":"Gastroenterology"},{"issue":"21","key":"5628_CR5","doi-asserted-by":"publisher","first-page":"11629","DOI":"10.3390\/ijms222111629","volume":"22","author":"J Gutierrez-Cuevas","year":"2021","unstructured":"Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: A link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021;22(21):11629.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5628_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11906-023-01242-8","volume":"25","author":"OO Badmus","year":"2023","unstructured":"Badmus OO, Hinds TD Jr., Stec DE. Mechanisms linking Metabolic-Associated fatty liver disease (MAFLD) to cardiovascular disease. Curr Hypertens Rep. 2023;25(8):151\u201362.","journal-title":"Curr Hypertens Rep"},{"key":"5628_CR7","doi-asserted-by":"publisher","first-page":"204201882211455","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, La Mantia C, Parisi S, Tulone A, Pennisi G, Grimaudo S, Petta S. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023;14:20420188221145549.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7","key":"5628_CR8","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/liv.14461","volume":"40","author":"X Cai","year":"2020","unstructured":"Cai X, Zheng S, Liu Y, Zhang Y, Lu J, Huang Y. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. Liver Int. 2020;40(7):1594\u2013600.","journal-title":"Liver Int"},{"key":"5628_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"5628_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12933-024-02171-9","volume":"23","author":"M Garofolo","year":"2024","unstructured":"Garofolo M, Lucchesi D, Giambalvo M, Aragona M, Bertolotto A, Campi F, Bianchi C, Francesconi P, Marchetti P, Del Prato S, et al. Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study. Cardiovasc Diabetol. 2024;23(1):85.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"5628_CR11","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"6","key":"5628_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"36","key":"5628_CR13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, De Potter TJR, Dwight J, Guasti L, Hanke T, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"5","key":"5628_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0010-4825(92)90023-G","volume":"22","author":"L Daly","year":"1992","unstructured":"Daly L. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med. 1992;22(5):351\u201361.","journal-title":"Comput Biol Med"},{"issue":"1","key":"5628_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12933-024-02408-7","volume":"23","author":"EJ Cho","year":"2024","unstructured":"Cho EJ, Chung GE, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Yu SJ. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol. 2024;23(1):340.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5628_CR16","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41598-021-83367-x","volume":"11","author":"SR Lee","year":"2021","unstructured":"Lee SR, Han KD, Choi EK, Oh S, Lip GYH. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. Sci Rep. 2021;11(1):3737.","journal-title":"Sci Rep"},{"key":"5628_CR17","doi-asserted-by":"publisher","first-page":"832023","DOI":"10.3389\/fcvm.2022.832023","volume":"9","author":"J Choi","year":"2022","unstructured":"Choi J, Lee SR, Choi EK, Ahn HJ, Kwon S, Park SH, Lee H, Chung J, Han M, Lee SW, et al. Non-alcoholic fatty liver disease and the risk of incident atrial fibrillation in young adults: A nationwide Population-Based cohort study. Front Cardiovasc Med. 2022;9:832023.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"5628_CR18","doi-asserted-by":"publisher","first-page":"e57183","DOI":"10.1371\/journal.pone.0057183","volume":"8","author":"G Targher","year":"2013","unstructured":"Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Rodella S, Zoppini G, Mantovani W, Barbieri E, Byrne CD. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS ONE. 2013;8(2):e57183.","journal-title":"PLoS ONE"},{"issue":"4","key":"5628_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/liv.14044","volume":"39","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dauriz M, Sandri D, Bonapace S, Zoppini G, Tilg H, Byrne CD, Targher G. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis. Liver Int. 2019;39(4):758\u201369.","journal-title":"Liver Int"},{"key":"5628_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310.","journal-title":"Eur J Intern Med"},{"issue":"10464","key":"5628_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"issue":"5","key":"5628_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/07853890.2018.1492147","volume":"50","author":"AJ Karajamaki","year":"2018","unstructured":"Karajamaki AJ, Hukkanen J, Ukkola O. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review. Ann Med. 2018;50(5):371\u201380.","journal-title":"Ann Med"},{"issue":"18","key":"5628_CR23","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/nu15183970","volume":"15","author":"K Yang","year":"2023","unstructured":"Yang K, Song M. New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk. Nutrients. 2023;15(18):3970.","journal-title":"Nutrients"},{"issue":"8","key":"5628_CR24","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.3390\/ijms22084241","volume":"22","author":"R Carnagarin","year":"2021","unstructured":"Carnagarin R, Tan K, Adams L, Matthews VB, Kiuchi MG, Marisol Lugo Gavidia L, Lambert GW, Lambert EA, Herat LY, Schlaich MP. Metabolic Dysfunction-Associated fatty liver disease (MAFLD)-A condition associated with heightened sympathetic activation. Int J Mol Sci. 2021;22(8):4241.","journal-title":"Int J Mol Sci"},{"key":"5628_CR25","doi-asserted-by":"crossref","unstructured":"Ng WH, Yeo YH, Kim H, Seki E, Rees J, Ma KS, Moylan CA, Rodriquez LM, Abdelmalek M, Villanueva A et al. Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data. Hepatology 2025.","DOI":"10.1097\/HEP.0000000000001333"},{"issue":"1","key":"5628_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol. 2024;23(1):346.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"5628_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12072-022-10449-x","volume":"17","author":"YM Cheng","year":"2023","unstructured":"Cheng YM, Wang CC, Kao JH. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications. Hepatol Int. 2023;17(2):350\u20136.","journal-title":"Hepatol Int"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05628-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:12:24Z","timestamp":1774519944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05628-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05628-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UKB study protocol was approved by the North West Multi-centre Research Ethics Committee (11\/NW\/0382).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}